Diet Pills By Cathy Chang

Article ObeseObese patients taking the weight-loss drug rimonabant also known as Acomplia have an increased risk of developing severe depression and anxiety, a new study reports. anxiety Obeseanxiety In addition to a potential risk of depression and anxiety, the FDA also found an increased chance of irritability, insomnia, panic attacks, aggression and suicide in patients taking the diet pill. Several patients taking rimonabant were prescribed antidepressants or tranquillizers to keep their symptoms under control. potentialirritability insomniapanic attacksaggressionantidepressantstranquillizerssymptomspotentialirritability insomniapanic attacksaggressionantidepressantstranquillizerssymptoms Evidence suggests that obese people may, on the whole, be even more prone to depression in the first place. prone Studies found a modest 5 percent to 10 percent decrease in weight in patients taking rimonabant. Study authors note that this weight loss would most likely not be sustained once treatment ended, and the patient would need to continue taking the drug for life to see lasting improvement in obesity-related risk factors. modest sustainedriskfactorsmodest sustainedriskfactors

Questions Have you ever worried about your weight? Have you ever worried about your weight? What have you done to loose weight? What have you done to loose weight? What do you think is the best way to loose weight? What do you think is the best way to loose weight? Why do you think that people would prefer to take diet pills? Why do you think that people would prefer to take diet pills? What has caused this focus on weight in today s society? What has caused this focus on weight in today s society?

Vocabulary Obese Obese Severe Severe Potential ;, Potential ;, Irritability Irritability Insomnia Insomnia Panic attacks Panic attacks Aggression Aggression Antidepressants Antidepressants Tranquilizers Tranquilizers Symptoms, Symptoms, Prone... Prone... Modest Modest Sustained ; Sustained ; Risk factors Risk factors

Reference Fait Acomplia? New Study Lends Weight to FDA Concerns Fait Acomplia? New Study Lends Weight to FDA Concerns – on/Story?id= &page=3